Literature DB >> 19270502

The axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells.

Chong Chen1, Yu Liu, Yang Liu, Pan Zheng.   

Abstract

It has been hypothesized that adult hematopoietic stem cells (HSCs) need to remain quiescent to retain their long-term self-renewal activity and multipotency. However, it is still unclear how lack of quiescence is detrimental to HSC. We identified that the mTOR pathway is the key to HSCs quiescence. mTOR overactivation caused increased mitochondrial biogenesis and accumulation of much higher level of reactive oxygen species (ROS). Removal of ROS rescued HSC defects associated with hyperactivated mTOR. We propose susceptibility to ROS as the underlying cause for HSC's general requirement for quiescence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270502     DOI: 10.4161/cc.8.8.8139

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  30 in total

Review 1.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

2.  The ups and downs of p53 regulation in hematopoietic stem cells.

Authors:  Hussein A Abbas; Vinod Pant; Guillermina Lozano
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

3.  Arrest of myelination and reduced axon growth when Schwann cells lack mTOR.

Authors:  Diane L Sherman; Michiel Krols; Lai-Man N Wu; Matthew Grove; Klaus-Armin Nave; Yann-Gaël Gangloff; Peter J Brophy
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

Review 4.  Mitophagy in hematopoietic stem cells: the case for exploration.

Authors:  Aashish Joshi; Mondira Kundu
Journal:  Autophagy       Date:  2013-10-11       Impact factor: 16.016

5.  Loss of fructose-1,6-bisphosphatase induces glycolysis and promotes apoptosis resistance of cancer stem-like cells: an important role in hexavalent chromium-induced carcinogenesis.

Authors:  Jin Dai; Yanli Ji; Wei Wang; Donghern Kim; Leonard Yenwong Fai; Lei Wang; Jia Luo; Zhuo Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-15       Impact factor: 4.219

Review 6.  The Dual Role of ROS in Hematological Malignancies: Stem Cell Protection and Cancer Cell Metastasis.

Authors:  Azin Samimi; Mohammad Javad Khodayar; Hadis Alidadi; Elahe Khodadi
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

7.  Heterogeneity of mitochondrial membrane potential: a novel tool to isolate and identify cancer stem cells from a tumor mass?

Authors:  Xiao-Qun Ye; Guang-Hui Wang; Gui-Jun Huang; Xiu-Wu Bian; Gui-Sheng Qian; Shi-Cang Yu
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

8.  Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence.

Authors:  Yi Luo; Lei Li; Ping Zou; Jie Wang; Lijian Shao; Daohong Zhou; Lingbo Liu
Journal:  Transplantation       Date:  2014-01-15       Impact factor: 4.939

Review 9.  mTORC signaling in hematopoiesis.

Authors:  Xiaomin Wang; Yajing Chu; Weili Wang; Weiping Yuan
Journal:  Int J Hematol       Date:  2016-01-20       Impact factor: 2.490

Review 10.  Autophagy in chronic myeloid leukaemia: stem cell survival and implication in therapy.

Authors:  Gudmundur V Helgason; Arunima Mukhopadhyay; Maria Karvela; Paolo Salomoni; Bruno Calabretta; Tessa L Holyoake
Journal:  Curr Cancer Drug Targets       Date:  2013-09       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.